Ocumension TherapeuticsOCUTF 52 Days Inventory is 46.17 as of Dec. 2025, which is 52% below its 10-year median of 96.32. GuruFocus rates OCUTF with a GF Score™ of 52/100 and a GF Value™ of $2.82 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 639 Biotechnology companies, Ocumension Therapeutics ranks better than 86.38% on this metric.
The historical rank and industry rank for Ocumension Therapeutics's Days Inventory or its related term are showing as below:
OCUTF'
s Days Inventory Range Over the Past 10 Years
Min: 44.41 Med: 96.32 Max: 9556.36
Current: 47.85
During the past 8 years, Ocumension Therapeutics's highest Days Inventory was 9556.36. The lowest was 44.41. And the median was 96.32.
OCUTF's Days Inventory is ranked better than 86.38% of 639
companies
in the Biotechnology industry
Industry Median: 183.97
vs OCUTF: 47.85
Ocumension Therapeutics's Days Inventory
declined
from Dec. 2024 (91.83) to Dec. 2025 (46.17).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ocumension Therapeutics's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.95.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ocumension Therapeutics's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.13.
Ocumension Therapeutics (OTCPK:OCUTF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ocumension Therapeutics's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ocumension Therapeutics's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ocumension Therapeutics Days Inventory Related Terms
Ocumension Therapeutics Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCUTF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Ocumension Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ocumension Therapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ocumension Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ocumension Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocumension Therapeutics (OCUTF) has a Days Inventory of 46.17 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ocumension Therapeutics and its competitors. This is 52% below median its historical median of 96.32. Over the past decade, Ocumension Therapeutics' Days Inventory has ranged from 44.41 to 9,556.36. According to the industry distribution chart, Ocumension Therapeutics ranks #87 out of 639 companies in the Biotechnology industry, placing it in the top 13.6%.
Is Ocumension Therapeutics' Days Inventory too high?
Ocumension Therapeutics' current Days Inventory of 46.17 is 52% below median its 10-year median of 96.32. Over the past 10 years, this metric has ranged from a low of 44.41 to a high of 9,556.36. The Biotechnology industry median Days Inventory is 183.97. Ocumension Therapeutics' value of 46.17 is 74.9% below this industry median. Based on the distribution chart, Ocumension Therapeutics ranks #87 out of 639 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ocumension Therapeutics has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ocumension Therapeutics' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ocumension Therapeutics ranks #87 out of 639 companies for Days Inventory. This places Ocumension Therapeutics in the top 14% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.97. Ocumension Therapeutics' value of 46.17 is 74.9% below this benchmark. Historically, Ocumension Therapeutics' own Days Inventory has ranged from 44.41 to 9,556.36 over the past decade. While the company's 10-year median is 96.32 vs. the industry median of 183.97, Ocumension Therapeutics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.97, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ocumension Therapeutics's current Days Inventory of 46.17 is 74.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ocumension Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocumension Therapeutics's current Days Inventory is 46.17, which is 52% below median its own 10-year median of 96.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocumension Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Ocumension Therapeutics (OCUTF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.82, compared to a current price of $0.70 — trading 75.2% below its estimated fair value. The current Days Inventory is 46.17, which is 52% below median its 10-year median of 96.32 and 74.9% below the Biotechnology industry median of 183.97. Ocumension Therapeutics' overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ocumension Therapeutics (OCUTF), the current Days Inventory is 46.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ocumension Therapeutics (OCUTF) Overvalued in 2026?
Based on GuruFocus' analysis, Ocumension Therapeutics stock appears to be undervalued.
The current stock price of $0.70 is trading 75.2% below its estimated GF Value™ of $2.82.
GuruFocus considers Ocumension Therapeutics to be Possible Value Trap.
Key valuation signals for OCUTF:
Days Inventory: 46.17 (52% below median its 10-year median of 96.32)
GF Value™: $2.82 vs. price of $0.70 (75.2% below fair value)
Industry Position: 74.9% below the Biotechnology median (#87 of 639)
No single metric tells the full story. See the OCUTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.
52GF Score
Get the complete analysis for OCUTF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCUTF has been successfully added to your 
